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The Physiological Basis for Vitamin C as a Potential Treatment for Sepsis 
Jennifer Johnston 
 
Abstract: Accounting for one third of all hospital patient deaths in America, sepsis remains one of the most deadly and complicated 
conditions that healthcare providers treat. Septic shock, a progressed form of sepsis, is even more troublesome, as mortality rates typically 
fall between 50-72%. It has been proposed that administration of high doses of vitamin C could be an effective treatment for the condition 
due to the nutrient’s anti-stress and anti-shock properties. This investigation of the physiological reasoning for administering high doses 
of vitamin C evaluates the viability of its use in patients with septic shock. 
t’s a grim diagnosis that no patient or family member is pre-
pared to hear, yet one that threatens the lives of hospitals’ 
sickest patients. Septic shock is an unforgiving condition with a 
poor prognosis unless caught and treated early.1 By definition, 
sepsis is the systemic release of inflammatory mediators in re-
sponse to a serious infection in the blood.1 Though this is 
typically treatable, if left uncontrolled it can progress to septic 
shock and cause dangerous hypotension.1 It might be 
perplexing that the body’s natural response to an infection is the 
root cause of such a grave disease, but its systemic nature of 
inflammation causes life-threatening complications.2 Afflicting 
1.7 million Americans each year, sepsis alone is responsible for 
one third of all patient deaths that occur in a hospital.3 Of the 
septic patients who progress into shock, mortality rates are 
typically between 50-72% depending on the infection’s origin.4 
Although current treatments yield low survival rates, research 
suggests that vitamin C has the potential to drastically improve 
this statistic.2,5 Because of the nutrient’s vital role in coordinating 
the body’s stress and shock responses, physicians are beginning 
to look towards vitamin C as a novel method of treating critically 
ill septic shock patients.2,6 
When an infection is present, a typical immune response in-
volves a cascade of events that prepare affected tissues for an 
influx of white blood cells to fight off foreign substances. One 
event involved in this cascade is the increased permeability of 
tissue endothelium to allow for easier transport of immune cells 
from the circulation to the site of infection.3 Septic shock, unlike 
localized infection, is characterized by increased endothelial 
permeability throughout the body.1 This causes a severe drop in 
blood pressure as blood rushes out of the vessels, through the 
endothelium, and into internal organs. Such a swift displacement 
of blood causes a myriad of further complications including 
tissue hypoxia, free radical accumulation, inhibition of 
catecholamine release, and systemic distribution of 
inflammatory mediators. If not immediately addressed, septic 
shock will ultimately lead to organ failure and death.2 
Current methods of treatment involve administration of large 
volumes of fluids, antibiotics, and vasopressors to stimulate an 
increase in blood pressure, but these are only effective if the 
condition is caught early.1,2 Hundreds of proposed treatments 
have progressed to late-phase clinical trials, but none have been 
effective in treating the systemic concerns of inflammation and 
cellular stress that typically precede organ failure in septic shock 
patients.2,6 But why do researchers look towards vitamin C as a 
treatment? While many key nutrients are depleted during septic 
shock, the majority are merely indicators of disease. Replacing 
these nutrients could be hazardous to the patient and further 
exaggerate the inflammatory response.6 Upon closer 
examination, scientists have found that vitamin C plays a vital 
role in many of the body’s natural processes that are typically 
suppressed in those with septic shock. This is evident in the 
various ways that vitamin C is linked to the maintenance of 
stable blood pressure.  
The primary cause of acute hypotension in septic shock patients 
is the sudden transfer of blood volume from the circulation to 
organ tissues due to the thinning of endothelial linings 
throughout the body. In a healthy individual, vitamin C is 
imperative in maintaining strong endothelial tissue and pre-
venting premature apoptosis of endothelial cells.8 Aside from 
maintaining the integrity of endothelium, vitamin C also enables 
blood vessels to respond to vasoconstrictors. In an attempt to 
elevate blood pressure, these compounds tighten blood vessels 
by causing smooth muscle contraction.7 In a septic shock 
patient, this pathway is inhibited by the enzyme, inducible nitric 
oxide synthase (iNOS) which counteracts vasoconstrictors’ 
effects and prevents blood vessels from effectively constricting 
in response to low blood pressure.7 Studies have shown that 
when vitamin C is reintroduced into the environment, it is 
successful in blocking endothelial iNOS and in effect allows 
vasoconstrictors to re-establish a stabilized blood pressure.7  
In addition to vasoconstrictors, other compounds work together 
to compensate for severe hypotension. Vasopressin, also known 
as antidiuretic hormone (ADH), is a prime example of one of 
these compounds. In a healthy individual, ADH is heavily in-
volved in the maintenance of an individual’s fluid balance and 
helps natural fluctuations in blood volume. When blood volume 
is extremely low during septic shock, ADH signals the kidneys to 
retain water in body circulation to compensate for fluid lost 
through the endothelium.2 While septic shock patients will likely 
experience significantly heightened levels of vasopressin at the 
onset of the condition, ADH levels diminish thereafter as vitamin 
C, a necessary cofactor in ADH production, is quickly depleted.2 
As a result, their blood pressure will continue to drop unless their 
physicians are able to reverse it in the early stages. 
I
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Vasopressin has multiple roles in the body that are not limited 
to just maintaining fluid balance. It additionally allows for the 
release of a substance called adrenocorticotropic hormone 
(ACTH), which causes the release of catecholamines like 
dopamine and epinephrine.2 These compounds are able to in-
crease the heart’s contractility and as a result, heighten the 
amount of blood circulating through the patient’s body.2 This is 
a desirable outcome in the case of septic shock patients. As 
would be expected, the inability to synthesize vasopressin due 
to a lack of vitamin C would result in serious dangers for a 
normal individual, but the consequences are even graver for 
septic shock patients who need dopamine and epinephrine to 
increase their cardiac output.2 
A direct result of severe hypotension, the trademark symptom 
of septic shock, is the concern of systemic hypoxia, or lack of 
oxygen throughout the body’s tissues.2,7 When tissues are in an 
oxygen-deprived state, they begin to produce extensive 
amounts of reactive oxygen species (ROS) which puts the tissues 
under a great deal of oxidative stress.2,3 Such stress causes 
damage to cells’ organelles, and if the build-up of ROS becomes 
severe enough, it threatens the functionality of endothelial 
cells.2,7 Vitamin C offers two possible solutions to this problem. 
It is capable of collecting ROS itself and is also capable of 
activating other ROS scavengers within the cell.2 By reducing the 
amount of ROS in the cell, the degree of cell damage from 
oxidative stress is effectively limited. Because of this, it is 
assumed that vitamin C could protect endothelial cells from 
further damage and in effect, prevent the infection from 
worsening.2,7  
Outside of vitamin C’s direct effects on blood pressure and 
oxidative stress, the nutrient also has more generic roles in the 
body that could be beneficial for septic shock patients. Because 
the underlying issue with septic shock is systemic inflammation, 
it should not come as a surprise to learn that inflammatory 
mediators are distributed throughout the body in a patient with 
this condition.2 The systemic presence of these molecules 
exacerbate the situation, because they encourage thinning of 
the endothelial layers and loosening at the junctions between 
endothelial cells, allowing a greater volume of blood to leave 
circulation.2 Studies have found that when ample amounts of 
vitamin C are present, the release of inflammatory mediators is 
blocked and the integrity of the endothelium is preserved.2,4,9 
Vitamin C also supports immune function as it is found in high 
concentrations in white blood cells and aids in chemotaxis which 
summons immune cells to the site of infection.2  
Despite strong rationale for the multi-faceted ability of vitamin 
C to reverse the effects of septic shock, physicians still have 
concerns with this treatment. One of the most prominent 
troubles with the idea of vitamin C usage is the possibility that 
individuals could develop renal failure as a result of 
administering doses as high as 6 grams daily to the patients.4,7 A 
study conducted through the University of Kansas Medical 
Center addressed this concern by surveying side effects 
observed by hospital physicians who had prescribed high doses 
of intravenous vitamin C to their patients at any point over the 
course of the previous year.10 Researchers found that the most 
prevalent side effect in patients was fatigue, noted in 59 of 9286 
patients.10 In the same sample of patients, only one was reported 
to have developed kidney failure by the end of the study and 
this particular patient had known renal tumors prior to the 
vitamin C treatment.10 To minimize the risk of patients falling 
into kidney failure after high dose vitamin C treatment, one 
physician found anecdotal success in administering a cocktail 
of  hydrocortisone and thiamine (vitamin B1) with vitamin C to 
his septic shock patients.4 The rationale is that renal failure would 
be a result of oxalate crystallization in the kidneys, but the 
presence of vitamin B12 reduces conversion of glyoxylate to 
oxalate so the likelihood of oxalate crystallization, and therefore 
kidney failure, would theoretically be much lower. While the 
ideology of a cocktail treatment like this one is plausible, further 
research needs to be conducted to determine its true efficacy.  
To assess the safety of administering high concentration, intra-
venous vitamin C to severe septic shock patients, a team of 
researchers led by Dr. Fowler of Virginia Commonwealth 
University’s School of Medicine conducted a study that collected 
patients’ responses to varying concentrations of vitamin C. A 
medical professional monitored patients’ vital signs in 5-minute 
intervals during and following the infusion and was instructed to 
remove the patient from treatment if any adverse effects were 
observed.9 At the conclusion of the study, the medical team 
reported zero adverse effects and improved organ function in 
the high dose vitamin C group.9 A different team of researchers 
conducted a similar study but focused on determining vitamin 
C’s role in maintaining a stable blood pressure. They found that 
the treatment group experienced lower mortality rates and 
required lower doses of exogenous vasopressors to maintain a 
sufficient blood pressure.11 Despite the encouraging findings of 
these studies, they share common limitations. Both had a small 
sample size (n=24 and n=28, respectively) and implemented 
inclusion criteria for the safety of the patients.9,11 While these 
study designs provide useful dosing information, their results 
cannot be generalized to fit the total septic shock population. In 
hopes of overcoming these limitations and reaching a reliable 
conclusion on the safety and efficacy of administering high 
doses of vitamin C to septic shock patients, two large-scale, 
double blind studies are currently being conducted in the United 
States and are expected to be completed in April 2019.12 
Research like this is exciting because the use of vitamin C to treat 
septic shock patients would be transformative considering its 
potential ability to act on many of the body systems affected by 
septic shock. From maintaining endothelial integrity and 
encouraging vasoconstrictor functionality, to aiding in the 
production of catecholamines and reducing oxidative stress 
within body cells, it is clear that vitamin C plays a vital role in 
many body processes at risk in septic shock. If high 
concentration, intravenous vitamin C administration is de-
termined to be both safe and successful in treating the entire 
spectrum of septic shock patients, then the prognosis for the 
disease would be much less daunting. This treatment method 
would be incredibly inexpensive, especially when compared to 
the currently available high-cost treatments that yield 
questionable success rates.2,12  A treatment as simple as vitamin 
C would also be accessible across the world and would not be 
limited to areas with the most advanced and expensive medical 
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technologies.12 Only time will tell if the treatment will live up to 
the hype that it is inspiring, but at least for now it is providing a 
ray of hope to an otherwise difficult to manage condition. 
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